logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Primary drug and age. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (i) Age distribution, New outpatient clients (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.13.915.219.720.716.112.511.733.64222737
Cocaine0.14.215.922.123.015.810.28.732.53016727
Stimulants1.118.526.422.014.68.35.24.027.5802612
Hypnotics and sedatives0.46.613.212.012.911.711.232.138.5354013
Hallucinogens0.228.335.417.79.33.52.23.524.84920
Volatile substances29.038.711.46.46.42.42.43.320.74210
Cannabis 4.434.425.615.49.15.13.12.924.35756379
Other substances 3.520.816.914.713.87.77.914.830.516574
Total2.017.420.118.315.910.97.77.629.3144093172
 

Notes

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-102 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Friday, 26 April 2013